Literature DB >> 1973838

Dinucleotide repeat polymorphisms at the D11S419 and CD3D loci.

J L Weber1, A E Kwitek, P E May.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1973838      PMCID: PMC331149          DOI: 10.1093/nar/18.13.4036

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


× No keyword cloud information.
  3 in total

1.  Abundant class of human DNA polymorphisms which can be typed using the polymerase chain reaction.

Authors:  J L Weber; P E May
Journal:  Am J Hum Genet       Date:  1989-03       Impact factor: 11.025

2.  The gene encoding the epsilon subunit of the T3/T-cell receptor complex maps to chromosome 11 in humans and to chromosome 9 in mice.

Authors:  D P Gold; J J van Dongen; C C Morton; G A Bruns; P van den Elsen; A H Geurts van Kessel; C Terhorst
Journal:  Proc Natl Acad Sci U S A       Date:  1987-03       Impact factor: 11.205

3.  Assignment of the gene coding for the T3-delta subunit of the T3-T-cell receptor complex to the long arm of human chromosome 11 and to mouse chromosome 9.

Authors:  P van den Elsen; G Bruns; D S Gerhard; D Pravtcheva; C Jones; D Housman; F A Ruddle; S Orkin; C Terhorst
Journal:  Proc Natl Acad Sci U S A       Date:  1985-05       Impact factor: 11.205

  3 in total
  12 in total

1.  Assignment of a gene (NEMI) for autosomal dominant nemaline myopathy to chromosome I.

Authors:  N G Laing; B T Majda; P A Akkari; M G Layton; J C Mulley; H Phillips; E A Haan; S J White; A H Beggs; L M Kunkel
Journal:  Am J Hum Genet       Date:  1992-03       Impact factor: 11.025

2.  Variation at the hepatic lipase and apolipoprotein AI/CIII/AIV loci is a major cause of genetically determined variation in plasma HDL cholesterol levels.

Authors:  J C Cohen; Z Wang; S M Grundy; M R Stoesz; R Guerra
Journal:  J Clin Invest       Date:  1994-12       Impact factor: 14.808

3.  Absence of linkage between idiopathic dilated cardiomyopathy and candidate genes involved in the immune function in a large Italian pedigree.

Authors:  M Krajinovic; L Mestroni; G M Severini; B Pinamonti; F Camerini; A Falaschi; M Giacca
Journal:  J Med Genet       Date:  1994-10       Impact factor: 6.318

4.  Three tumor-suppressor regions on chromosome 11p identified by high-resolution deletion mapping in human non-small-cell lung cancer.

Authors:  G Bepler; M A Garcia-Blanco
Journal:  Proc Natl Acad Sci U S A       Date:  1994-06-07       Impact factor: 11.205

5.  Possible association of CD3 and CD4 polymorphisms with insulin-dependent diabetes mellitus (IDDM).

Authors:  M Z Ghabanbasani; I Buyse; E Legius; R Decorte; P Marynen; R Bouillon; J J Cassiman
Journal:  Clin Exp Immunol       Date:  1994-09       Impact factor: 4.330

6.  Absence of linkage to the ataxia telangiectasia locus in familial breast cancer.

Authors:  R Wooster; D Ford; J Mangion; B A Ponder; J Peto; D F Easton; M R Stratton
Journal:  Hum Genet       Date:  1993-08       Impact factor: 4.132

7.  Analysis of a second family with hereditary non-chromaffin paragangliomas locates the underlying gene at the proximal region of chromosome 11q.

Authors:  E C Mariman; S E van Beersum; C W Cremers; F M van Baars; H H Ropers
Journal:  Hum Genet       Date:  1993-05       Impact factor: 4.132

8.  Functional evidence for a second tumor suppressor gene on human chromosome 17.

Authors:  P Chen; N Ellmore; B E Weissman
Journal:  Mol Cell Biol       Date:  1994-01       Impact factor: 4.272

9.  No evidence for linkage between familial hypertriglyceridemia and apolipoprotein B, apolipoprotein C-III or lipoprotein lipase genes.

Authors:  T Heliö; A Palotie; T Sane; M J Tikkanen; K Kontula
Journal:  Hum Genet       Date:  1994-09       Impact factor: 4.132

10.  The autosomal dominant familial exudative vitreoretinopathy locus maps on 11q and is closely linked to D11S533.

Authors:  Y Li; B Müller; C Fuhrmann; C E van Nouhuys; H Laqua; P Humphries; E Schwinger; A Gal
Journal:  Am J Hum Genet       Date:  1992-10       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.